About The Medical Condition EN1639A
Find the definition of the medical term EN1639A. EN1639A defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
EN1639A
| EN1639A Medical Condition |
|---|
What's The Definition Of The Medical Condition EN1639A?
Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Canada ‐ The largest country in North America, comprising 10 provinces…
- Tranquilizing Agents, Minor ‐ Agents that alleviate anxiety, tension, and neurotic symptoms,…
- Plant Disease ‐ Diseases…
- Sensation, Hyperalgesic ‐ An increased sensation to painful stimuli that may follow damage…
- Proteins, Viral ‐ Proteins found in any species…
- Alcohol-NAD+ Oxidoreductase ‐ A zinc-containing enzyme which oxidizes primary and secondary…
- Vitiligo ‐ A disorder consisting of areas of macular depigmentation, commonly…
- Oplopanax ‐ A plant genus in the family ARALIACEAE, order Apiales, subclass…
- Insulin Shock Therapy ‐ The use of convulsive agents to influence favorably the course…
- Transferases, N-Acetylgalactosamine ‐ Enzymes that catalyze the transfer of N-acetylgalactosamine from…